BioCentury
ARTICLE | Company News

Amarin, Laxdale deal

October 18, 2004 7:00 AM UTC

AMRN completed its previously announced acquisition of Laxdale for 3.5 million ADSs, which values Laxdale at $3.8 million based on AMRN's Oct. 11 close of $1.09 (see BioCentury, July 19). ...